1. S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION. (23rd June 2022) Authors: Müller-Tidow, C.; Janssen, M.; Schäkel, U.; Gall, J.; Leo, A.; Stelmach, P.; Krisam, J.; Baumann, L.; Stermann, J.; Merle, U.; Zeier, M.; Weigand, M. A.; Bullinger, L.; Schrezenmeier, J.-F.; Bornhäuser, M.; Alakel, N.; Witzke, O.; Wolf, T.; Vehreschild, M. J.; Schmiedel, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗